Aurora Cannabis Inc. (TSX: ACB) announced today that, further to its press release of November 14, 2017, it intends to make an offer to purchase all of the issued and outstanding common shares of CanniMed Therapeutics Inc. (TSX: CMED) for consideration consisting of common shares of Aurora.
